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Effect of 1 ,25-dihydroxycholecalciferol on impaired calcium
transport by the sarcoplasmic reticulum in experimental uremia. In
the fragmented sarcoplasmic reticulum from skeletal muscle of
rabbits with experimental uremia, defective calcium ion transport
is found. An impairment of all parameters is observed (initial rate
of uptake, storing capacity with and without oxalate, and con-
centrating ability). In viva administration of 1,25-dihydroxychole-
calciferol (l,25-(OH),-vitamin D,)(2 )< 27 ng X kg of body wt'
>< day 'and 6 X 27 ng X kg' X day', respectively) improved the
kinetic parameters. The low dose improved storing capacity, and
the higher dose, in addition to the storing capacity, also corrected
concentrating ability and the initial rate of uptake. It is concluded
that active calcium transport in the sarcoplasmic reticulum is im-
paired by uremia and that this defect is responsive to the adminis-
tration of I ,25-(OH ),.vitamin D,.
Effet du I ,25-dihydroxycholecalciferol sur l'altération du trans-
port du calcium par le reticulum sarcoplasmique dans l'urémie ex-
périmentale. Un défaut du transport du calcium est observe dans Ic
reticulum sarcoplasmique du muscle squelettique de lapins atteints
d'urémie chronique expérimentale. Une alteration de tous les pa-
ramètres est observée (debit initial de captation, capacite de misc
en reserve avec et sans oxalate, capacite de concentration).
L'administration in vivo de l,25-(OH),-vitamine D, (2 X 27 ng X
kg' X jour' ou 6 X 27 ng X kg' X jour') améliore les pars-
metres cinétiques. La dose faible améliore Ia capacité de mise
en reserve et Ia dose Ia plus élevée corrige, outre Ia capacité de mise
en reserve, Ia capacité de concentration et le debit initial de capta-
tion. La conclusion est que le transport actif de calcium dans Ic
reticulum sarcoplasmique est altéré par l'urémie et que ce deficit est
corrigé par l'administration de l,25-(OH),-vitamine D,.
Uremic patients often suffer from a peculiar form
of metabolic myopathy which is characterized by
proximal muscle weakness [I]. Based on clinical ob-
servations, Stanbury hypothesized that a defect of
calcium ion transport in sarcoplasmic reticulum (SR)
may be present. Histochemical [2] and electrophysio-
logic studies (Senges, Ehe, Ritz: Uremic myopathy:
Changes in contractile and membrane properties, in
preparation) have also shown abnormalities of ske-
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letal muscle in clinical and experimental uremia. It is
well established that the regulation of muscular con-
traction and relaxation is calcium-dependent. It is
believed that the sarcoplasmic reticulum brings about
muscular contraction by liberating calcium ions to
the sarcoplasm in response to the arrival at the
muscle of a nerve impulse, and that it then causes
muscular relaxation by sequestering the released cal-
cium ions again by an active transport process. A
defect of calcium ion transport by sarcoplasmic reti-
culum has been demonstrated in experimental uremia
[3, 4]. The following paper provides evidence that
1 ,25—dihydroxycholecalciferol (1 ,25-(OH)2—vitamin
D), the active metabolite of vitamin D, can reverse
the impairment of active calcium transport by the
sarcoplasmic reticulum in experimental uremia.
Methods
Inbred New Zealand rabbits (Graflich Degenfeld
Schonberg'sches Rentamt; Versuchstierfarm Eybach,
Geislingen, Germany) of either sex (body wt, 2 to 3
kg) were used for the experiments. Uremia was in-
duced in the animals by removal of the right kidney
under sodium pentobarbital anesthesia (Nembutal®,
30 mg/kg of body wt) using a transabdominal ap-
proach. At least two-thirds of the left kidney was
destroyed by ligation of the branches of the left renal
artery. The kidneys were decapsulated in order to
preserve the adrenal glands. Penicillin (250,000 IU)
was given i.v. immediately after the operation. Simul-
taneously, the control animals were sham-operated
(decapsulation of both kidneys). The animals were
kept in single cages and pair-fed after operation with
commercially available artificial food (M ischfutter
fur Kaninchen, J. Zahn Co., Flockenheim, Ger-
many). The animals had free access to water and were
killed five days after nephrectomy. During this time
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serum urea rose from 29 7 mg/100 ml (controls) to
186 + 104 mg/100 ml, and serum creatinine rose from
1.10 + 0.2 mg/100 ml (controls) to 4.1 + 1.8 mg/100
ml (Technicon Autoanalyzer, model SMA 12). Se-
rum calcium was 4.5 + 0.8 mEq/liter (controls, 5.2
0.5 mEq/liter), and serum potassium was 4.5 + 0.9
mEq/liter (controls, 5.4 + 0.6 mEq/liter).
l,25-(OH)2-vitamin D, dissolved in alcohol and
kept at 4°C in the dark, was administered per os
according to the time schedule given in Table 1. Se-
rum calcium concentrations decreased after nephrec-
tomy (uremic, 4.5 to 0.8 mEq/liter; controls, 5.2 to
0.4 mEq/liter) and rose again in animals treated with
1,25- (OH)2-vitamin D3 (2 X 27 ng/kg of body wt X
24 hr). 25-(OH)-vitamin D concentrations, measured
with the technique of Edelstein [5], were slightly
higher in uremic animals than in control animals.
Neither control rabbits (serum 25-(OH)-vitamin D,
38.2 3.85 nmoles/liter) nor uremic rabbits (serum
25-(OH)-vitamin D, 55.14 + 7.37 nmoles/liter) were
vitamin D-depleted.
Two dose levels of l,25-(OH)2-vitamin D3 were
chosen: a low dose of 2 X 27 ng/kg of body weight X
24 hr for the period of 5 days, and high dose of(6 X
6 X 27 ng/kg of body weight >< 24 hr for a period of
five days.
!'reparation of sarcoplasmic reticulum. The experi-
ments designed to evaluate the effect of 1,25-(OH)2-
vitamin D3 in experimental uremia were performed
using one uremic animal, one uremic animal treated
with l,25-(OH)2-vitamin D3, and one sham-operated
control animal. To study any possible effect of 1,25-
(OH)2-vitamin D3 on the controls, additional paired
experiments were performed comparing one sham-
operated control with one sham-operated control re-
ceiving the high dose of l,25-(OH)2-vitamin D3. The
sarcoplasmic reticulum was isolated according to Dc
Meis and Hasselbach [6] from the leg and back mus-
cles, the control and uremic animals yielding the
same amount of vesicles per gram of wet muscle. The
entire preparation procedure was performed in the
presence of lO-4M pheynylmethyl sulfonylfluoride
(PMSF), an inhibitor of proteinases, especially tryp-
sin and chymotrypsin. This has been done because
tissue proteinases are known to be more active in
certain pathological conditions. The vesicles were
kept at 4°C and were used within two days after
preparation.
Presence of a higher degree of non-sarcoplasmic
reticulum protein and mitochondrial impurities in the
"uremic" preparation were excluded by 1) poly-
acrylamide gel electrophoresis [4], 2) electron micro-
Table 1. The effect of 1,25 (OH)2-vitamin D3 on SR calcium transport parameters in experimental uremiao
Initial rate of uptake"
flM (a mg'
Concentrating ability Storing capacitye
5 mM oxalate no oxalate
protein min' nM calciumo Joule's mole e n Ca . mg' of protein
Uremia, N 6 1870 + 536" 20.5 795 12083 + 829" 3253 + 733" 254 88
Uremia, low dose 1,25'N 6 1885 805 20.5 6.5 12083 626 3643 581' 332 + 62
Control, N = 6 2685 + 402 14.1 3.7 12888 626 5158 1020 354 + 198
Uremia, N 6 2217 296" 12.9 4.5" 13127 835" 6044 + 1548" 501 129
High dose 1,25", N = 6 2730 + 322' 9.0 + 1.9' 13885 + 489' 8243 + 2494 542 + HO
Control, N 6 2768 + 514 11.1 4.8 13500 + 920 7320 1607 662 317
Control. N 6
Control, high dose 1,25".
2768 517
2984 670
11.4 5.8
9.2 + 1.3
13482 991
13813 + 323
5535 + 1859 470 + 88
6219 2157 368 + 156
N=6 NS NS NS NS NS
° The Wilcoxon test was used to evaluate paired differences; all experiments were performed using three (rsp. two) animals in parallel as
described under "Preparation of sarcoplasmic reticulum."
Rate of calcium uptake expressed is within first 30 sec after start of the reaction; the reaction was linear from 0 to 2 mm, as demonstrated
previously (Fig. 3)[4}.
Concentrating ability is expressed by the free calcium concentration in the incubation medium after 20 mm of calcium uptake. Incubation
medium contained EGTA (0.2 mM) and the reaction was started by addition of vesicles; pH = 7.0. Free calcium concentration was calcu-
lated from the remaining radioactivity in the incubation medium and the Ca-EGTA complex constant after Schwarzenbach [291.
Maximum transmembrane osmotic gradient built up by the vcsicles based on the values from footnote c and on an apparent soluhility
product olcalcium-oxalate of2 X 10_s [81, which in the presence of5 mi oxalate results in a free calcium concentration inside of4 X 10-6 M.
Storing capacity expressed by the amount of calcium taken up within 20 mm of reaction. The assay contained excess calcium (0.2 mM),
5 mM oxalate as the precipitating anion (rsp. no precipitating anion) and 0.01 mg of vesicular protein per ml; pH = 7.0.
Low dose 2 X 27 ng/kg X 24 hr.
O High dose = 6 X 27 ng/kg )< 24 hr.
Difference between uremia and control, P < 0.05.
Difference between uremia and treated, P < 0.05.
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scopy, and 3) incubation with sodium azide, which is
known to inhibit mitochondrial ATPase activity [7].
Calcium kinetics. The kinetic studies were per-
formed by simultaneous incubation of control sample
and experimental sample(s) at room temperature us-
ing the following standard conditions [8]: 5 mM aden-
osine triphosphate; 10 m magnesium chloride; 20
mM histidine; 40 mi potassium chloride; 5 mM oxa-
late; 0.1 mvi calcium (+45Ca); 5 m'i phosphoenol-
pyruvate (PEP); 50 ig of pyruvate kinase/mI; 0.05
mg of vesicular protein per ml; pH, 7.0; ionic strength() = 0.1. Specific conditions of incubation are given
in the figure legends. The reaction was stopped by
filtration of aliquots through millipore filters (Schlei-
cher und Schull, Selectron-Filter, Type 8A85; pore
size, O.4Si), and the difference between the radio-
activity of the filtrate and the initial activity of the
incubation medium was used to calculate the kinetic
data.
Statistics. The difference between the paired con-
trol animals and experimental animals was evaluated
with the use of Wilcoxon's test for paired differences.
The figures are given as X + SD.
Electron microscopy. For electron microscopy,
samples of SR preparations from control, uremic,
and l,25-(OH)2-vitamin D3-treated uremic animals
were negatively stained on collodion and carbon
coated grids according to standard procedures [9].
They were then observed in the electron microscope
within a few minutes after air drying. A 1% potassium
phosphotungstate aqueous solution adjusted to a pH
of 7.0 with potassium hydroxide (KOH) was used.
An electron microscope (Siemens Elmiskop, Model
101) equipped with a specimen cooling device was
used with a double condenser illumination, 300 um Pt
and 30 tm Pt condensers and 30 im Pt objective
aperture, accelerating voltage of 80 kV and an emis-
sion current of 20 isA. Pictures were taken at a magni-
fication ranging from X 10,000 to X40,000.
Results
It has been shown that the vesicle membrane not
only is able to transform a chemical potential into an
osmotic potential [10] but also can transform an os-
motic potential back into a chemical potential [II].
The whole transport reaction can be described
stoichiometrically by the following equation:
2Ca0+ATP+C0± 2Ca1+ADP+C+P+J-I
where C is the hypothetical transport unit carrier;
indices "o" and "i" represent outside and inside the
membrane, respectively; P1 represents orthophos-
phate. For each mole of adenosine triphosphate
(ATP) split, two moles of calcium ions are trans-
ported [8]. The energy linked calcium flux rates
through the membrane thus can be described by:
Va flux = Ca02 X ATP >< C0 X k1
— Ca12 >< ADP X P, X C1 X k1 (ib)
Including the electrochemical terms, which, however,
are unlikely to contribute to the energetic balance
[12], the relation between osmotic and chemical po-
tential at equilibrium then can be described by:
eVXF Ca2RXt Ca02
ATP X C0 X k+1
>< kATPADP X P1 >< C, X k1x H
(2)
where R = gas constant, T = absolute temperature
(K°), V = difference of electrical potential, F = Fara-
day constant, and kATP = equilibrium constant of
ATP. (See definitions of equation 1 for C0, C1, Ca0,
Ca1, k+1, k_1 and P1.)
Two groups of kinetic parameters can be distin-
guished: first, parameters determined in the absence
of calcium uptake equilibrium (initial kinetics); and
second, parameters determined in the presence of
calcium uptake equilibrium (steady state kinetics).
From equations lb and 2 it can be seen that the
principal factors which can affect transport kinetics
are either the number of carrier transport units, C0
(outside) and C1 (inside), and/or the rate constants,
k+1 and k1. Comparison of equations lb and 2
shows that both factors influence both the initial and
steady state kinetics. Therefore, an alteration of one
factor should result in a change of all kinetic parame-
ters. In the presence of high osmotic gradients, the
kinetics of the membrane are additionally affected by
passive calcium ion fluxes. Thus, the rate constant,
carrier population, and passive calcium ion per-
meability ultimately characterize the membrane
transport properties.
In uremia it was found [4] that all transport param-
eters are impaired. The present communication de-
scribes the effect of l,25-(OH)2-vitamin D3 on trans-
port kinetics in uremic animals.
Initial rate of influx. In Figure 1, the calcium ion
exchange of control and uremic membranes is com-
pared after preequilibration in the absence of net
calcium ion uptake, i.e., during steady state. It can be
seen that calcium ion exchange of the uremic mem-
branes is slower than that of the control membranes.
(la) Defining the influx rate constant (K1) by the terms
given above
K = C0 X k1
= Va influx at equilibrium/Ca02 X ATP, (3)
it was calculated [4] that the influx rate constant of
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the uremic membranes is decreased. This decreased
influx rate constant is consistent with the decreased
initial influx rate of the uremic membranes (see Table
1).
The initial influx rate measured under nonsteady
state conditions [8] was not consistently normalized
by the low dose of l,25-(OH)2-vitamin D3, but in-
creased significantly after in vivo administration of
the higher dose of I ,25-(OH)2-vitamin D3. In the dose
given, l,25-(OH)2-vitamin D3 failed to affect signifi-
cantly the initial influx rate of the vesicles of non-
uremic animals. Finally, the addition of l,25-(OH)2-
vitamin D3 to the incubation medium in vitro at a
concentration of 0.027 ng/ml and 0.54 ng/ml was
without any effect on the initial rate of influx.
Concentrating ability. As documented in Table 1,
the rate of calcium ion uptake is diminished in
uremia. In addition, a previous communication de-
scribed an increased passive efflux [4]. These two
changes explain why concentrating ability, i.e., the
capacity to lower ambient calcium ion concentration,
is diminished in vesicles of uremic animals. A mea-
sure of concentrating ability is given in Table 1 by the
free calcium ion concentration "outside" after cessa-
tion of net calcium ion uptake and by the correspond-
ing osmotic potential. Because of the use of an ATP
2.0 regenerating system, the chemical potential in the
control and uremic assay is identical. The osmotic
potential, however, built up from this chemical po-
1.9 g tential, is approximately 10% less in uremic mem-
branes compared to the controls. Concentrating abil-
1.8 ity was not significantly affected by the admin-: istration of the low dose of L25-(OH)2-vitamin
D3. In contrast, the administration of the high dose of
1,7 1,25-(OH)2-vitamin D3 increased significantly the
concentrating ability of the vesicles of uremic animals
1 6
but failed to affect significantly the concentrating
ability of the vesicles of nonuremic animals.
Storing capacity. Storing capacity is a measure-
ment of the maximal amount of calcium taken up by
the vesicles in the presence of excess calcium and
ATP. This parameter is determined after cessation of
net calcium ion uptake in the presence of a very low
osmotic gradient. It therefore depends neither on the
influx rate constant nor to a great extent on the
permeability to calcium ions; it does depend, how-
ever, on vesicle geometry and/or vesicle leakiness,
e.g., incomplete sealing. Storing capacity was
markedly diminished in the uremic preparations and
was increased by the in vivo administration of 1,25-
(OH)2-vitamin D3, both in low and especially in high
doses (Table I).
Electron micrographic studies. Figure 2a shows a
negatively stained preparation from the SR of a con-
trol rabbit. As reported previously [9], vesicular
structures of various sizes and shapes can be ob-
served. The vesicles are covered either with fine 40 A
particles or exhibit an electron dense rim. On the
average the vesicles from the uremic nontreated rab-
bit (Fig. 2b) appear smaller than those from the
control. The fine surface structure of the vesicle prep-
aration from the uremic nontreated rabbit, however,
does not appear to be altered. No significant differ-
ence between the SR preparations from control and
l,25-(OH)2-vitamin Drtreated uremic animals (Fig.
2c) could be found. Scattered open vesicles, mito-
chondrial fragments, and filamentous structures can
be detected only occasionally in all three prepara-
tions.
Discussion
In uremia, it could consistently be shown that all
parameters of active calcium ion transport in the
sarcoplasmic reticulum (SR) of skeletal muscles are
altered, the effect being responsive to l,25-(OH)2-
vitamin D3. These findings provide an interesting in
vitro model to study the effects of uremia on an active
cation transport system.
Exclusion of experimental artifacts. An increase of
+ Tracer Ca ss
100"
50
(0
0I-
25 + EGTA, 10—6M
10 2O25 30
Time, rn/n
Fig. I. Calcium exchange at steady slate of calcium uptake. The
graph gives one typical experiment. Assay conditions were chosen
as described under Methods. The initial calcium concentration in
the medium was 100 1aM; 45Ca was added to give an initial counting
rate of 20000 counts/mm/mI. After 10 mm of preincubation, 0.1
mM EGTA was added to the assay (left side of the graph). After
another 15 mm of equilibration, when steady state conditions were
established as confirmed by repeated measurements of 45Ca, a
small amount of 45Ca of high specific activity was added in tracer
amounts (right side of the graph). The influx rate constant was
calculated 14] from the slope of the disappearance of activity
(ordinate to the right), neglecting the first component (steep de-
cline) which is thought to reflect membrane binding. The solid line
represents vesicles from control rabbits: the broken line represents
vesicles from uremic rabbits.
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Fig. 2. Electron micrographs of negatively slained SR vesicles from control, a; uremic, b; and 1,25-DHCC treated uremic, C, rabbits. In b,
vesicles appear on the average smaller than in a. Negative staining was done with 1% potassium phosphotungstate, pH, 7.0; X80,000.
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non-SR material, especially mitochondria, within the
uremic preparation could be excluded by gel-elec-
trophoresis, sodium azide, which showed no inhibi-
tion of the ATPase activity, and by electron micro-
scopy. The impairment of the kinetic parameters is
not likely to result from an eventual tryptic destruc-
tion of the uremic membranes since a trypsin inhib-
itor (lO-4M phenylmethyl sulfonyifluoride) was added
to all the steps of the vesicle preparation. Also, less
complete sealing of the uremic vesicles during the
preparation procedure is unlikely, since differential
centrifugation of uremic vesicles after completion of
calcium ion uptake failed to show a higher propor-
tion of vesicles with little or no calcium ion uptake
ability compared to the controls. The presence of
inhibitors in the assay system is unlikely, since a
possible inhibitor should be lost during the prepara-
tion procedure with several washing steps.
Histological studies of Bundschu, Suchenwirth,
and Durr [2] showed that the relative number of
white, type II fibers of skeletal muscles is decreased in
uremia, while a relative increase of red, type I fibers
and of intermediary fibers occurs. A relative increase
of vesicles from red muscle fibers within the uremic
preparation should be reflected by an increased cal-
cium-independent ATPase activity of the uremic
preparation [13]. Such an increase, however, was not
observed in the system under study [4]. It is known
that the vesicles tend to form clusters at higher pro-
tein concentrations. This had the consequence of di-
minishing the relative calcium ion flux rates, calcu-
lated per mg of protein, by diminishing the
transporting surface. Kinetic studies at different pro-
tein concentrations revealed the same relative decrease
of calcium transport in vesicles of uremic animals.
In addition, reduction of the transporting surface
would fail to explain the change of transport ratio
observed in previous experiments [4], Recently, it has
been suggested that phosphorylase kinase may have
an activating effect on calcium ion transport [14]. The
impaired calcium ion kinetics are most likely not the
result of less phosphorylase kinase in the uremic
preparation, since the ATPase activities of both pre-
parations did not differ [4] and, furthermore, since
significant changes of the gel-electrophoretic pattern
of both preparations in regard to non-SR proteins
were not observed. The defect observed, therefore,
must be due to a direct change of vesicular membrane
properties.
Transport kinetics. Net uptake of calcium ions can
be regarded as a result of active inward transport and
passive diffusional outward loss along osmotic gradi-
ents (pump-leak model). Three possible models for
diminished net inward flux of calcium ions can there-
fore be envisaged as: I) diminished unidirectional
influx, 2) increased outward leak, 3) both diminished
influx and increased leak.
The passive efflux observed in the presence of high
osmotic calcium ion gradients [4] points to an in-
creased passive calcium ionic permeability of the
uremic membranes. The initial rate of calcium ion
uptake is measured at high calcium concentrations in
the incubation in the absence of ethylene glycol his
(fl-aminoethyl ether)-N, N tetraacetic acid (EGTA),
thus establishing a minimal osmotic gradient at the
beginning of the calcium ion uptake reaction. As
shown previously [4], in the presence of a small os-
motic gradient, the passive efflux from the uremic
vesicles cannot possibly account for the diminution
of net inward flux, since the initial rate of uptake of
uremic vesicles was shown to be lower by an average
of 556 flM calcium/mg of protein, while the passive
efflux rate, measured under the optimal conditions of
a high osmotic gradient, was increased in uremic vesi-
des only by an average of 5 nM calcium/mg of pro-
tein X mm. Furthermore, energy dependent efflux is
unlikely to be markedly different in the uptake ex-
periment, since under controlled conditions of identi-
cal chemo-osmotic potential, energy dependent efflux
was not found to be significantly different between
uremic and control vesicles [4]. Therefore, decreased
unidirectional influx can not be explained by in-
creased active or passive calcium ion effiuxes during
uptake, but instead by anyone or all of the following:
a decrease of the rate constant, a decrease of the
number of transport sites, uncoupling between trans-
port ATPase and calcium transport.
Uncoupling between ATP breakdown and calcium
transport is suggested by the findings reported in a
previous paper [4]. Since passive calcium ion fluxes
through the membrane cannot pass through its lipoid
moiety [15], the increased passive calcium ion efflux
observed in the uremic membranes indicates an alter-
ation of the protein moiety of the membrane due
either to an altered primary structure and/or to al-
tered lipid-protein interactions. An alternative ex-
planation would be a change in vesicle size, suggested
by our electron micrograph studies, which by virtue
of increasing surface/volume ratio might provide for
an increase of passive calcium ionic permeability.
Storing capacity, a kinetic parameter largely inde-
pendent of either influx rate constant or calcium ionic
permeability, might also be affected by change of
vesicle leakiness (e.g., incomplete sealing) or vesicle
geometry. Relating to the influence of vesicular ge-
ometry, loaded vesicles of normal animals were cen-
trifuged through a discontinuous sucrose gradient
after completion of net calcium ion uptake (unpub-
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lished experiments). The vesicles of the pellet frac-
tion, which presumably had the highest calcium ion
content were found to have the smallest diameter
when evaluated by electron microscopy. The results
of the kinetic experiments may be interpreted ther-
modynamically by stating that the rate and efficiency
of calcium ion transport, i.e., the conversion of chem-
ical potential to osmotic potential, is diminished. This
is indicated by the calculations given in Table 1.
Electron microscopy. No tendency of individual SR
vesicles to cluster could be observed in the uremic
preparation. The vesicular membrane does not ap-
pear to be altered with the applied technique, and only
a reduction in the vesicular size can be detected. As
has been shown in other pathological conditions [16],
this might possibly reflect a greater nonspecific fragil-
ity of SR from uremic animals, the result being the
formation of smaller vesicles during the preparation
procedure. No significant changes could be observed
on the preparation of l,25-(OH)2-vitamin D3-treated
uremic animals, which, in agreement with the bio-
chemical results, suggests that the uremic alteration
may be prevented by treatment with 1,25-(OH)2-vita-
mm D3.
Relevance to in vivo muscle function. Impaired cal-
cium ion uptake was observed not only in the pres-
ence of oxalate, a nonphysiological precipitator of
calcium ions, but also in the presence of phosphate
[3], approximately 2mM of which has been estimated
to be present in skeletal muscle [17]. The results,
however, do not necessarily imply that the defect
observed in vitro can manifest itself in disturbed
muscle relaxation in vivo. Experiments of our group
on the diaphragm of uremic rats showed that the
relaxation time, which is related to the velocity of
intracellular sequestration of calcium ions, is not
prolonged in uremia (Senges, Ehe, Ritz: Uremic
myopathy: Changes in contractile and membrane
properties, in preparation). There are various expla-
nations for the apparent discrepancy between the in
vitro and in vivo findings. First of all, the first step of
calcium ion sequestration in muscle is probably due
to calcium ions binding to free calcium ionic binding
sites of SR rather than to calcium ion transport [18].
Secondly, there is also evidence that in the absence of
precipitating anions, i.e., under conditions more re-
lated to the in vivo situation, the calcium ion trans-
port process of SR is different from that observed in
the presence of these anions [19—2 1]. Since vesicles of
uremic animals were able to lower ambient calcium
ion concentration below 2 X lO-, the relaxation
threshold of the actomyosin system, unimpaired re-
laxation is possible in spite of impaired calcium ion
uptake. Total muscle calcium has not been measured
in these experiments; however, a decrease of total
muscle calcium might account for the ability of
uremic muscle to efficiently lower cytosolic calcium
ion concentration in spite of a diminished net calcium
ion transport rate. Finally, it cannot be excluded that
steps other than sarcoplasmic calcium ion transport
(e.g., dissociation of calcium from troponin) are rate
limiting in the relaxation process.
Biochemical consequences of uremia unrelated to the
calcium ion transport defect. Experimental uremia is
associated with increased blood urea concentrations,
metabolic acidosis, secondary hyperparathyroidism,
calorie and protein malnutrition, and uremic poly-
neuritis. These factors are unlikely to be the cause of
the findings observed, since administration of urea in
drinking water, induction of metabolic acidosis by
ammonium chloride, and administration of bovine
parathyroid hormone did not result in comparable
changes of the vesicular function [22, 23]. The differ-
ence between control and uremic animals was still
present when food was completely withheld; protein-
calorie malnutrition can further be excluded, since
pairfeeding was performed in all experiments re-
ported above. Most likely, the vesicular transport
defect is not the result of uremic polyneuritis, since
the difference between uremic and control animals
was still present when the hind limbs were paralyzed
by sectioning of the sciatic nerve [22, 23].
Effect of vitamin D metabolites. In the above dis-
cussion, the system could be defined kinetically and a
variety of artifacts or non-vitamin D related factors
could be excluded as the cause of the transport defect
in uremia. In the following we discuss the evidence
that this defect is related to a disturbance of vitamin
D metabolism. At the dose used, 1,25-(OH)2-vitamin
D3 failed to increase significantly transport parame-
ters in nonuremic control animals. This excludes the
possibility that we are dealing only with a pharma-
cologic effect of 1,25-(OH)2-vitamin D3. Neither con-
trol nor uremic animals were vitamin D-depleted,
since 25-(OH)-vitamin D levels were in the normal
range. This excludes the possibility that we are deal-
ing with repletion of vitamin D or 25-(OH)-vitamin
D deficiency. Renal synthesis of 1,25-(OH)2-vitamin
D, the active metabolite of vitamin D, is impaired in
renal insufficiency [24]. Deficiency of l,25-(OH)2-
vitamin D appears to be the cause of the impairment
of the function of the sarcoplasmic reticulum in
uremia. Whereas in previous experiments, in vivo ad-
ministration of vitamin D or 25-(OH)-vitamin D at
the one dose level in the supraphysiological range
prior to nephrectomy failed to correct the defect of
calcium ion kinetics observed in uremia [25], re-
peated administration of 1,25-(OH)2-vitamin D3 at
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the high dose level (as opposed to bolus injection of
l,25-(OH)2-vitamin D3 [251) improved defective stor-
ing capacity, concentrating ability, and initial rate of
calcium ion uptake. At the low dose level, only the
storing capacity was consistently improved over the
nontreated uremic animals. The higher dose of 1,25-
(OH)2-vitamin D3 completely restored to normal all
calcium ionic transport parameters. The greater sen-
sitivity of storing capacity to l,25-(OH)2-vitamin D3
may imply dependence of this parameter on mem-
brane properties, binding or nucleation phenomena
not reflected in the kinetics of the uptake experiment,
or else it may result from the more favorable condi-
tions under which storing capacity is measured (i.e.,
optimal ATP concentration and calcium ion gradi-
ent). The lower of the doses used was similar to the
one which has recently been shown to improve the
calcemic response of the skeleton to parathyroid hor-
mone (PTH) infusion in uremic dogs [26].
As discussed above, the diminished rate of initial
uptake of calcium ions results primarily from a di-
minished calcium ion influx rate constant (K2).
Therefore, the action of l,25-(OH)2-vitamin D3 can-
not be explained by an effect on passive calcium ionic
permeability. The increase in passive effiux, though
demonstrable in uremia [4], is unable to account for
the diminished rate of initial calcium ion uptake for
quantitative reasons. We are unable to decide
whether the action of 1 ,25-(OH)2-vitamin D3 is due to
the generation of additional transport sites or due to
an increase in the rate constant, or due to both. A
thermodynamic interpretation of the action of 1,25-
(OH)2-vitamin D3 would be that the rate and effi-
ciency of calcium ion transport is increased, i.e., the
ability to convert chemical potential into osmotic
potential. The effect of 1 ,25-(OH)2-vitamin D3 appar-
ently is an indirect one, since in vitro incubation of
the vesicles with 1,25-(OH)2-vitamin D3 in concentra-
tions equivalent to circulating l,25-(OH)2-vitamin D3
levels failed to correct the transport defect.
These results demonstrate that skeletal muscle is an
important target organ for vitamin D. This is also
suggested by the result of Birge and Haddad that 25-
(OH)-vitamin D affects muscle metabolism [27] as
well as by the findings of Curry, Francis and Smith
that the function of the sarcoplasmic reticulum is
impaired in vitamin D deficiency [28]. The sarcoplas-
mic reticulum, being a well established model of ac-
tive transporting membranes, might well provide an
effective in vitro model of a subcellular system to
elucidate the multisystem effects of uremia on cal-
cium ion transport.
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